Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Journal of Organic Chemistry|June 19, 2004
concise synthesis of 4-acylamino analogues of 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acids (LY354740) from an acylnitroso Diels-Alder cycloadductWenlin Lee, Marvin J MillerThe Journal of Organic Chemistry|January 8, 2003
Stereo- and regioselectivity of Pd(0)/InI-mediated allylic additions to aldehydes and ketones. In situ generation of allylindium(III) intermediates from N-acylnitroso Diels-Alder cycloadducts and 1-amino-4-acetoxycyclopentenesWenlin Lee, Kyung-Hee Kim, Matthew D Surman, et al.Journal of the American Chemical Society|August 9, 2003
Structural aspects for evolution of beta-lactamases from penicillin-binding proteinsSamy O Meroueh, George Minasov, Wenlin Lee, et al.Journal of the American Chemical Society|December 25, 2003
A mechanism-based inhibitor targeting the DD-transpeptidase activity of bacterial penicillin-binding proteinsMijoon Lee, Dusan Hesek, Maxim Suvorov, et al.Journal of Alternative and Complementary Medicine (New York, N.Y.)|June 26, 2008
Improvement of agreement in TCM diagnosis among TCM practitioners for persons with the conventional diagnosis of rheumatoid arthritis: effect of trainingGrant G Zhang, Betsy Singh, Wenlin Lee, et al.Journal of Alternative and Complementary Medicine (New York, N.Y.)|July 5, 2005
Variability in the traditional Chinese medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritisGrant G Zhang, Wenlin Lee, Barker Bausell, et al.Explore (New York, N.Y.)|June 20, 2006
Involvement of peripheral opioid mechanisms in electroacupuncture analgesiaGrant G Zhang, Chengsi Yu, Wenlin Lee, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2006
Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillationBenjamin E Blass, Keith Coburn, Wenlin Lee, et al.Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)Michael P Clark, Kelly M George, Roger G Bookland, et al.Pageof 1